Literature DB >> 25735244

Introduction of human pharmaceuticals from wastewater treatment plants into the aquatic environment: a rural perspective.

Carolina Nebot1, Raquel Falcon, Kenneth G Boyd, Stuart W Gibb.   

Abstract

Incomplete removal of pharmaceuticals during wastewater treatment can result in their discharge into the aquatic environment. The discharge of pharmaceuticals in wastewater treatment plant (WWTP) effluents into rivers, lakes and the oceans has led to detectable concentrations of pharmaceuticals in the aquatic environment in many countries. However, to date studies of WWTP discharges into the aquatic environment have largely been confined to areas of relatively high population density, industrial activity or systems impacted on by such areas. In this work, two sites in the far north of Scotland were used to assess whether, and which, pharmaceuticals were being introduced into natural waters in a rural environment with low population density. Samples from two WWTPs (with differing modes of operation), and one receiving water, the River Thurso, were analysed for the presence of 12 pharmaceuticals (diclofenac, clofibric acid, erythromycin, ibuprofen, mefenamic acid, paracetamol, propranolol, sulfamethoxazole, tamoxifen, trimethoprim and dextropropoxyphene). Ten of the 12 pharmaceuticals investigated were detected in at least one of the 40 WWTP effluent samples. Maximum concentrations ranged from 7 ng L(-1) (sulfamethoxazole) to 22.8 μg L(-1) (paracetamol) with diclofenac and mefenamic acid being present in all of samples analysed at concentrations between 24.2 and 927 ng L(-1) and 11.5 and 22.8 μg L(-1), respectively. Additionally, the presence of four pharmaceuticals at ng L(-1) levels in the River Thurso, into which one of the WWTPs discharges, shows that such discharges result in measurable levels of pharmaceuticals in the environment. This provides direct evidence that, even in rural areas with low population densities, effluents from WWTPs can produce quantifiable levels of human pharmaceutical in the natural aquatic environment. These observations indicate that human pharmaceuticals may be considered as contaminants, with potential to influence water quality, management and conservation not only in urban and industrial regions but also those more rural in nature.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25735244     DOI: 10.1007/s11356-015-4234-z

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  44 in total

1.  Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low-ng/l level in surface and waste water.

Authors:  S Ollers; H P Singer; P Fässler; S R Müller
Journal:  J Chromatogr A       Date:  2001-03-16       Impact factor: 4.759

2.  Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  T Ternes; M Bonerz; T Schmidt
Journal:  J Chromatogr A       Date:  2001-12-14       Impact factor: 4.759

3.  Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Martin J Hilton; Kevin V Thomas
Journal:  J Chromatogr A       Date:  2003-10-10       Impact factor: 4.759

4.  Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.

Authors:  Marta Carballa; Francisco Omil; Juan M Lema; María Llompart; Carmen García-Jares; Isaac Rodríguez; Mariano Gómez; Thomas Ternes
Journal:  Water Res       Date:  2004-07       Impact factor: 11.236

5.  The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment.

Authors:  Paul H Roberts; Kevin V Thomas
Journal:  Sci Total Environ       Date:  2005-06-02       Impact factor: 7.963

6.  Elimination of beta-blockers in sewage treatment plants.

Authors:  M Maurer; B I Escher; P Richle; C Schaffner; A C Alder
Journal:  Water Res       Date:  2007-02-15       Impact factor: 11.236

7.  Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital effluent wastewaters.

Authors:  M José Gómez; Mira Petrović; Amadeo R Fernández-Alba; Damià Barceló
Journal:  J Chromatogr A       Date:  2006-03-20       Impact factor: 4.759

8.  Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry.

Authors:  Carolina Nebot; Stuart W Gibb; Kenneth G Boyd
Journal:  Anal Chim Acta       Date:  2007-07-14       Impact factor: 6.558

9.  Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment.

Authors:  Jian-Liang Zhao; Guang-Guo Ying; You-Sheng Liu; Feng Chen; Ji-Feng Yang; Li Wang
Journal:  J Hazard Mater       Date:  2010-03-03       Impact factor: 10.588

10.  The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.

Authors:  Barbara Kasprzyk-Hordern; Richard M Dinsdale; Alan J Guwy
Journal:  Water Res       Date:  2008-05-10       Impact factor: 11.236

View more
  7 in total

1.  Occurrence and behaviour of pharmaceutical compounds in a Portuguese wastewater treatment plant: Removal efficiency through conventional treatment processes.

Authors:  Vanessa de Jesus Gaffney; Vitor Vale Cardoso; Eugénia Cardoso; Ana Paula Teixeira; José Martins; Maria João Benoliel; Cristina Maria Martins Almeida
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-01       Impact factor: 4.223

2.  Degradation of quinolone antibiotic, norfloxacin, in aqueous solution using gamma-ray irradiation.

Authors:  Murtaza Sayed; Javed Ali Khan; Luqman Ali Shah; Noor S Shah; Hasan M Khan; Faiza Rehman; Abdur Rahman Khan; Asad M Khan
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-28       Impact factor: 4.223

3.  Geo-referenced simulation of pharmaceuticals in whole watersheds: application of GREAT-ER 4.1 in Germany.

Authors:  Volker Lämmchen; Gunnar Niebaum; Jürgen Berlekamp; Jörg Klasmeier
Journal:  Environ Sci Pollut Res Int       Date:  2021-01-07       Impact factor: 4.223

4.  Features of diclofenac biodegradation by Rhodococcus ruber IEGM 346.

Authors:  Irina B Ivshina; Elena A Tyumina; Maria V Kuzmina; Elena V Vikhareva
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

5.  Diclofenac Degradation-Enzymes, Genetic Background and Cellular Alterations Triggered in Diclofenac-Metabolizing Strain Pseudomonas moorei KB4.

Authors:  Joanna Żur; Artur Piński; Danuta Wojcieszyńska; Wojciech Smułek; Urszula Guzik
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

Review 6.  Rhodococcus strains as a good biotool for neutralizing pharmaceutical pollutants and obtaining therapeutically valuable products: Through the past into the future.

Authors:  Irina Ivshina; Grigory Bazhutin; Elena Tyumina
Journal:  Front Microbiol       Date:  2022-09-29       Impact factor: 6.064

7.  Time study on the uptake of four different beta-blockers in garden cress (Lepidium sativum) as a model plant.

Authors:  Franz Mlynek; Markus Himmelsbach; Wolfgang Buchberger; Christian W Klampfl
Journal:  Environ Sci Pollut Res Int       Date:  2020-11-18       Impact factor: 4.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.